Heart failure with preserved ejection fraction in children: Hormonal imbalance between aldosterone and brain natriuretic peptide

Circulation Journal

Volumn 77, Issue 9, 2013, Pages 2375-2382

  Masutani, Satoshi ^a   Saiki, Hirofumi ^a   Kurishima, Clara ^a   Ishido, Hirotaka ^a   Tamura, Masanori ^a   Senzaki, Hideaki ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Aldosterone; Brain natriuretic peptide; Diastolic heart failure

Indexed keywords

ALBUMIN; ALDOSTERONE; ANGIOTENSIN II; BRAIN NATRIURETIC PEPTIDE; CREATININE; POTASSIUM;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEATH; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; FALLOT TETRALOGY; FEMALE; FOLLOW UP; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART HYPERTROPHY; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTENSION; INFANT; LUNG VEIN DRAINAGE ANOMALY; MALE; MORTALITY; PRESCHOOL CHILD; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HEART FAILURE;

ADOLESCENT; ADULT; AGE FACTORS; ALDOSTERONE; CARDIOMEGALY; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HEART FAILURE; HUMANS; INFANT; MALE; NATRIURETIC PEPTIDE, BRAIN; RETROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL RATE;

EID: 84882763001     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-1271     Document Type: Article

References (31)

1. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, et al. How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiog-raphy Associations of the European Society of Cardiology. Eur Heart J 2007; 28: 2539-2550.
2. Owan TE, Redfeld MM. Epidemiology of diastolic heart failure. Prog Cardiovasc Dis 2005; 47: 320-332.
3. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfeld MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-259.
4. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002; 288: 2144-2150.
5. Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure: Abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004; 350: 1953-1959.
6. Kass DA, Bronzwaer JG, Paulus WJ. What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 2004; 94: 1533-1542.
7. Lam CS, Donal E, Kraigher-Krainer E, Vasan RS. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail 2010; 13: 18-28.
8. Little WC. Heart failure with a normal left ventricular ejection fraction: Diastolic heart failure. Trans Am Clin Climatol Assoc 2008; 119: 93-99; discussion 99-102.
9. Maurer MS, Burkhoff D, Fried LP, Gottdiener J, King DL, Kitzman DW. Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: The Cardiovascular Health Study. J Am Coll Cardiol 2007; 49: 972-981.
10. Zile MR, Gaasch WH, Anand IS, Haass M, Little WC, Miller AB, et al. Mode of death in patients with heart failure and a preserved ejection fraction: Results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation 2010; 121: 1393-1405.
11. Liu Y, Haddad T, Dwivedi G. Heart failure with preserved ejection fraction: Current understanding and emerging concepts. Curr Opin Cardiol 2013; 28: 187-196.
12. Ishibashi N, Park IS, Waragai T, Yoshikawa T, Murakami Y, Mori K, et al. Effect of carvedilol on heart failure in patients with a functionally univentricular heart. Circ J 2011; 75: 1394-1399.
13. Inokuchi M, Hasegawa T, Sasaki R, Hori N, Kosaki K, Anzo M, et al. The cross-sectional BMI growth curves for Japanese from birth to 17 years of age: The 2000-2001 National Survey data: Comparison with the 1990-1994 data and the 1978-1981 data. Clin Pediatr Endo-crinol 2003; 12: 122.
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantifcation: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantifcation Writing Group, developed in conjunction with the European Association of Echocar-diography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
15. Daniels SR, Meyer RA, Liang YC, Bove KE. Echocardiographi- cally determined left ventricular mass index in normal children, adolescents and young adults. J Am Coll Cardiol 1988; 12: 703-708.
16. Matsubara H, Takaki M, Yasuhara S, Araki J, Suga H. Logistic time constant of isovolumic relaxation pressure-time curve in the canine left ventricle: Better alternative to exponential time constant. Circulation 1995; 92: 2318-2326.
17. Senzaki H, Chen CH, Masutani S, Taketazu M, Kobayashi J, Kobayashi T, et al. Assessment of cardiovascular dynamics by pressure-area relations in pediatric patients with congenital heart disease. J Thorac Cardiovasc Surg 2001; 122: 535-547.
18. Raff GL, Glantz SA. Volume loading slows left ventricular isovolu-mic relaxation rate: Evidence of load-dependent relaxation in the intact dog heart. Circ Res 1981; 48: 813-824.
19. Senzaki H, Kamiyama MP, Masutani S, Ishido H, Taketazu M, Kobayashi T, et al. Effcacy and safety of torasemide in children with heart failure. Arch Dis Child 2008; 93: 768-771.
20. He GW. Current strategy of repair of tetralogy of Fallot in children and adults: Emphasis on a new technique to create a monocusp-patch for reconstruction of the right ventricular outfow tract. J Card Surg 2008; 23: 592-599.
21. Cheung YF, Wong SJ, Liang XC, Cheung EW. Torsional mechanics of the left ventricle in patients after surgical repair of tetralogy of Fallot. Circ J 2011; 75: 1735-1741.
22. Krymsky LD. Pathologic anatomy of congenital heart disease. Circulation 1965; 32: 814-827.
23. Iwamoto Y, Tamai A, Kohno K, Masutani S, Okada N, Senzaki H. Usefulness of respiratory variation of inferior vena cava diameter for estimation of elevated central venous pressure in children with cardiovascular disease. Circ J 2011; 75: 1209-1214.
24. Murakami T, Takeda A. Enhanced aortic pressure wave refection in patients after repair of aortic coarctation. Ann Thorac Surg 2005; 80: 995-999.
25. Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: Implications for systolic and diastolic reserve limitations. Circulation 2003; 107: 714-720.
26. Sunagawa K, Maughan WL, Burkhoff D, Sagawa K. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol 1983; 245: H773-H780.
27. Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, et al. B-type natriuretic peptide strongly refects diastolic wall stress in patients with chronic heart failure: Comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006; 47: 742-748.
28. Zannad F, Dousset B, Alla F. Treatment of congestive heart failure: Interfering the aldosterone-cardiac extracellular matrix relationship. Hypertension 2001; 38: 1227-1232.
29. Weber KT. Aldosterone and spironolactone in heart failure. N Engl J Med 1999; 341: 753-755.
30. Nishikimi T, Maeda N, Matsuoka H. The role of natriuretic peptides in cardioprotection. Cardiovasc Res 2006; 69: 318-328.
31. Ito T, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, Harada E, et al. Inhibitory effect of natriuretic peptides on aldoste-rone synthase gene expression in cultured neonatal rat cardiocytes. Circulation 2003; 107: 807-810.